NCT02795052 - Neurologic Stem Cell Treatment Study | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions

Neurologic DisordersNervous System DiseasesNeurodegenerative DiseasesNeurological DisordersStrokeTraumatic Brain InjuryCadasilChronic Traumatic EncephalopathyCerebral InfarctionCerebral IschemiaCerebral StrokeCerebral HemorrhageParkinsonMulti-System DegenerationMSA - Multiple System AtrophyProgressive Supranuclear PalsyALSAmyotrophic Lateral SclerosisNeuropathyDiabetic NeuropathiesAlzheimer DiseaseDementiaFrontotemporal DementiaLewy Body DiseaseCognitive ImpairmentLewy Body Variant of Alzheimer Disease

Interventions

PROCEDURE

Intravenous and Intranasal BMSC

Autologous Bone Marrow Derived Stem Cells provided intravenous and intranasal (lower 1/3 of nose)

Trial Locations (3)

33065

RECRUITING

MD Stem Cells, Coral Springs

06880

RECRUITING

MD Stem Cells, Westport

337-1500

RECRUITING

The Saudi-German Hospital, Dubai